Eric Sherbet Biography and Net Worth

Insider of IQVIA

Eric Sherbet is executive vice president, general counsel for IQVIA, The Human Data Science Company™. He is responsible for the company’s global legal operations, as well as compliance, privacy and external affairs.

Eric has more than 25 years of legal experience, of which 17 are in the global life science and technology industries. Prior to joining IQVIA in February 2018 , he served as general counsel and secretary at Patheon, where he oversaw the company’s initial public offering and its recent $7.2 billion acquisition by Thermo Fisher.

Before that, Eric was general counsel and secretary at InVentiv Health, where he built the legal and compliance division into a global team. He also served as vice president, deputy general counsel and corporate secretary at Foster Wheeler AG and as vice president, corporate and securities law and corporate secretary at Avaya.

Eric earned his J.D. from the New York University School of Law and received his bachelor’s degree in commerce/accounting from the University of Virginia. Eric started his career as a CPA at KPMG.

What is Eric Sherbet's net worth?: The estimated net worth of Eric Sherbet is at least $3.85 million as of August 27th, 2024. Mr. Sherbet owns 19,536 shares of IQVIA stock worth more than $3,853,867 as of December 21st. This net worth estimate does not reflect any other investments that Mr. Sherbet may own. Additionally, Mr. Sherbet receives an annual salary of $1,370,000.00 as Insider at IQVIA. Learn More about Eric Sherbet's net worth.
How old is Eric Sherbet?: Mr. Sherbet is currently 60 years old. There are 4 older executives and no younger executives at IQVIA. The oldest executive at IQVIA is Mr. Ari Bousbib, CEO & Chairman, who is 63 years old. Learn More on Eric Sherbet's age.
What is Eric Sherbet's salary?: As the Insider of IQVIA Holdings Inc., Mr. Sherbet earns $1,370,000.00 per year. There are 2 executives that earn more than Mr. Sherbet. The highest earning executive at IQVIA is Mr. Ari Bousbib, CEO & Chairman, who commands a salary of $7,150,000.00 per year. Learn More on Eric Sherbet's salary.
How do I contact Eric Sherbet?: The corporate mailing address for Mr. Sherbet and other IQVIA executives is 4820 EMPEROR BOULEVARD, DURHAM NC, 27703. IQVIA can also be reached via phone at (919) 998-2000 and via email at [email protected]. Learn More on Eric Sherbet's contact information.
Has Eric Sherbet been buying or selling shares of IQVIA?: Eric Sherbet has not been actively trading shares of IQVIA during the last ninety days. Most recently, Eric Sherbet sold 1,300 shares of the business's stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $246.33, for a transaction totalling $320,229.00. Following the completion of the sale, the insider now directly owns 19,536 shares of the company's stock, valued at $4,812,302.88. Learn More on Eric Sherbet's trading history.
Who are IQVIA's active insiders?: IQVIA's insider roster includes Ari Bousbib (Insider), Ronald Bruehlman (Insider), John Connaughton (Director), John Danhakl (Director), Kevin Knightly (Insider), Michael McDonnell (CFO), Ronald Rittenmeyer (Director), and Eric Sherbet (Insider). Learn More on IQVIA's active insiders.
Are insiders buying or selling shares of IQVIA?: In the last year, insiders at the medical research company sold shares 4 times. They sold a total of 42,585 shares worth more than $10,651,231.53. The most recent insider tranaction occured on August, 27th when insider Eric Sherbet sold 1,300 shares worth more than $320,229.00. Insiders at IQVIA own 1.6% of the company. Learn More about insider trades at IQVIA.
Information on this page was last updated on 8/27/2024.

Eric Sherbet Insider Trading History at IQVIA

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/27/2024	Sell	1,300	$246.33	$320,229.00	19,536
2/16/2024	Sell	1,000	$241.50	$241,500.00	20,836
2/14/2023	Sell	1,000	$230.00	$230,000.00	17,053

Eric Sherbet Buying and Selling Activity at IQVIA

IQVIA Company Overview

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Today's Range

Now: $197.27

$191.44

$200.14

50 Day Range

MA: $208.90

$190.97

$236.61

2 Week Range

Now: $197.27

$187.62

$261.73

Volume

3,345,878 shs

Average Volume

1,204,975 shs

Market Capitalization

$35.80 billion

P/E Ratio

25.89

Dividend Yield

N/A

Beta

1.49

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

Eric Sherbet Biography and Net Worth

What is Eric Sherbet's net worth?

How old is Eric Sherbet?

What is Eric Sherbet's salary?

How do I contact Eric Sherbet?

Has Eric Sherbet been buying or selling shares of IQVIA?

Who are IQVIA's active insiders?

Are insiders buying or selling shares of IQVIA?